National Guideline Clearinghouse | Topotecan for the treatment of relapsed small-cell lung cancer.

National Institute for Health and Clinical Excellence (NICE).
Guideline Title
Topotecan for the treatment of relapsed small-cell lung cancer.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Topotecan for the treatment of relapsed small-cell lung cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Nov. 31 p. (Technology appraisal guidance; no. 184).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Topotecan for the treatment of relapsed small-cell lung cancer.